Skip to main content

Day: May 28, 2025

LPL Financial Welcomes Mai Park Capital to Linsco Channel

SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisor Mai Park, CPWA®, has joined LPL’s employee advisor channel, Linsco by LPL Financial, aligning with existing firm Pence Wealth Management, to launch Mai Park Capital. She reported serving approximately $330 million in advisory, brokerage and retirement plan assets* and joins LPL from Merrill Lynch. Based in Newport Beach, Calif., Park transitioned to financial services in 2007 following a career as a high school science teacher. With more than 20 years of industry experience, Park focuses on estate planning, investment management, retirement planning, tax planning and wealth management, taking a holistic and comprehensive approach with the goal of fostering meaningful, multi-generational relationships. “Every client’s financial...

Continue reading

Form 8.3 – [Craneware]

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Danske Bank A/S(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Craneware PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position...

Continue reading

Helport AI to Participate in the Baird Global Consumer, Technology & Services Conference on June 3-5, 2025

SINGAPORE and SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) — Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), an AI technology company serving enterprise clients with intelligent customer communication software and services, today announced that Amy Fong, President & Interim Chief Financial Officer, will participate in the Baird Global Consumer, Technology & Services Conference taking place at the InterContinental New York Barclay Hotel on June 3-5, 2025. Baird’s Global Consumer, Technology & Services Conference is a renowned event among consumer, technology & services sector players. This invite-only conference brings together institutional and private equity investors with senior management from approximately 250 public and privately held companies for idea sharing, presentations and networking. In...

Continue reading

Volcon ePowersports Obtains Floor Plan Program with Dealer Direct Financing

AUSTIN, Texas, May 28, 2025 (GLOBE NEWSWIRE) — Volcon ePowersports (Nasdaq: VLCN) (“Volcon” or the “Company”), the first all-electric, off-road powersports company, is pleased to announce the launch of a new floor plan financing and retail financing program provided by Dealer Direct Financial, a department of First Community Bank. This initiative will enable Volcon’s network of dealers to finance their inventory purchases, providing them with enhanced access to the Company’s groundbreaking electric off-road vehicles. The floor plan will provide flexible financial solutions designed to support inventory acquisition and drive sales of Volcon’s cutting-edge products. By facilitating dealer access to affordable financing, Volcon aims to expand its market presence and ensure that customers nationwide...

Continue reading

Alpha Tau to Present at Jefferies Global Healthcare Conference

JERUSALEM, May 28, 2025 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present at the Jefferies Global Healthcare Conference on June 5, 2025.Event: Jefferies Global Healthcare ConferenceFormat: PresentationDate: June 5, 2025Time: 1:25 – 1:55PM ETLocation: New York, NY   Mr. Levy will be available for 1×1 investor meetings. Please reach out to your Jefferies representative to schedule. About Alpha Tau Medical Ltd.Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially...

Continue reading

Primech A&P Secures New Contracts and Extensions Worth Over $2.6 Million for Q1 2025

SINGAPORE, May 28, 2025 (GLOBE NEWSWIRE) — Primech A & P, a subsidiary of Primech Holdings Limited (the “Company”) (Nasdaq: PMEC), an established technology-driven facility services provider in the public and private sectors operating mainly in Singapore, today announced several newly secured contracts and extensions for the first quarter of 2025, with a total value exceeding $2.59 million. The latest contract wins and extensions include:Secured a 2-year contract (January 2025 to December 2026) valued at $774,470 for public area cleaning and housekeeping services at a prominent international hotel chain in Singapore’s prime Orchard Road shopping district.  Secured a 2-year contract (April 2025 to March 2027) valued at $676,150 for comprehensive cleaning services at a premium residential condominium development.  Secured...

Continue reading

iTeos Therapeutics Announces Its Intention to Wind Down Operations

– Board of Directors intends to cease operations – Company to focus efforts on selecting best path to deliver near-term value to shareholders – Exploring potential asset sales including EOS-984, EOS-215, and a preclinical obesity program targeting ENT1 WATERTOWN, Mass. and GOSSELIES, Belgium, May 28, 2025 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced the intention to wind down its operations as part of a comprehensive review of strategic alternatives aimed at maximizing shareholder value. Following a thorough assessment of the Company’s development pipeline, business prospects, and financial position, the Company’s Board of Directors...

Continue reading

A Smarter Way to Pay: Giftify’s CardCash Launches Buy Now, Pay Later with ZIP

SCHAUMBURG, IL, May 28, 2025 (GLOBE NEWSWIRE) — Giftify, Inc. (NASDAQ: GIFT) (the “Company”), the owner and operator of CardCash.com and Restaurant.com, and a leader in the incentives and rewards industry, today announced that CardCash.com (“CardCash”) has launched a Buy Now, Pay Later (BNPL) flexible payment plan option through a new partnership with Zip Co. (ASX: ZIP), a digital financial services company offering innovative and people-centered products. CardCash customers can now split their gift card purchases into easy payments directly at checkout. The new BNPL integration is designed to make CardCash even more accessible to shoppers who want to save money while maintaining flexibility in how they pay. Buy Now, Pay Later solutions have gained significant popularity in recent years, especially among Millennials...

Continue reading

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study

First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold Resumption of dosing in this study triggers a $10M milestone payment from GSK plus an additional $20M milestone due in six months; as previously disclosed GSK disputes these milestone payments, and SCYNEXIS vigorously disagrees with their positionJERSEY CITY, N.J., May 28, 2025 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that patient dosing has resumed in the Phase 3 MARIO study, which is an innovative study to investigate oral ibrexafungerp as a potential step-down antifungal therapy following IV echinocandin for invasive candidiasis, a life-threatening infection. The study had been...

Continue reading

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

Experienced medical device executive with deep expertise in implantable technologies joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology RUTHERFORD, N.J., May 28, 2025 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today that Victoria E. Carr-Brendel, PhD, was elected to the Company’s Board of Directors, effective May 22, 2025. “We are delighted to welcome Dr. Carr-Brendel to Glucotrack’s Board of Directors,” said Paul V. Goode, PhD, President and Chief Executive Officer of Glucotrack. “With her exceptional leadership in medical devices and deep expertise in implantable technologies, she will be an invaluable addition to the Board...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.